Earlier, I published a lengthy blog message about Ebola.

Article below copied from The Daily Dose newsletter, received October 9, 2014.

– –

Has America’s first Ebola death exposed a cover-up?

In some isolated ward in Dallas’ Texas Health Presbyterian Hospital… probably surrounded by nurses in Hazmat suits… Thomas Eric Duncan drew his last breaths yesterday. He became the first death on American soil from the growing Ebola outbreak.

Since the minute Duncan slipped through our porous borders and touched down in America, his case has provided more questions than a round of Jeopardy.

How did a man with Ebola sneak through a Liberian airport onto a plane headed for America? How did hospital workers send a sick Duncan home — even AFTER he admitted he was visiting from Africa?

And those are the easy questions, friend.

Because Duncan’s death has exposed a new, deeply troubling question that is hanging like a dark cloud over the entire global health community. It’s a question that could undermine our trust in the same health officials who are supposed to keep us safe.

Did the United States intentionally deny Duncan an Ebola treatment that could have saved his life?

By now you know the story of two American aid workers whose lives were saved this summer with doses of the anti-Ebola drug ZMapp. They seemed to bounce back within days after ZMapp treatment began.

But when Duncan took sick, U.S. Centers for Disease Control and Prevention head Thomas Frieden claimed there wasn’t a drop of ZMapp left on the planet. He claimed it was “all gone” and “was not going to be available any time soon.”

Except no one seemed to tell the Norwegians.

Because according to the country’s national health agency, a dose of ZMapp is on its way to Norway… RIGHT NOW… to help a sick aid worker who took ill DAYS after Duncan. This is allegedly the “real” last dose of the medication.

The world wasn’t out of ZMapp, as it turns out. The world… or at least some folks in very high positions of authority… simply decided that Duncan wasn’t going to get any.

He was put on a highly experimental drug brincidofovir, an unproven medication that had just recently received emergency FDA approval, and was dead a couple days later.

There could be lots of reasons a Norwegian aid worker is getting the last ZMapp dose instead of Duncan. But let’s not overlook the most obvious.

She’s a heck of a lot more sympathetic.

There aren’t going to be any elementary schools named after Duncan, who allegedly lied his way into America and would have been prosecuted in Liberia. Lord knows the damage he could have caused — or perhaps already did.

So, trust me, my sympathies for Duncan don’t run high. If someone decided to give ZMapp to an aid worker instead of Duncan, maybe it was even the right decision.

But Duncan’s case still demands answers. Why were we told there were no doses of ZMapp available? Who decides who gets the drug and who doesn’t?

It’s time for us to get a peek behind the curtain. Let’s just hope we don’t find some government bureaucrat playing God.

Digging for answers,

William Campbell Douglass II, M.D.